Senseonics (SENS) vs Tactile Systems Technology (TCMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Tactile Systems Technology (TCMD) has outperformed Senseonics (SENS) over the past year, gaining 48.5% versus a loss of 2.4%. Over five years, TCMD leads with a -37.7% price change compared with -86.3% for SENS. Tactile Systems Technology is the larger company by market cap ($505.8 million vs $469.5 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | SENS | TCMD |
|---|---|---|
| Share price | $8.88 | $22.33 |
| Market cap | $469.52M | $505.83M |
| 1-day change | -1.55% | +0.95% |
| YTD return | +63.41% | -23.72% |
| 1-year return | -2.38% | +48.46% |
| 5-year return | -86.33% | -37.69% |
| P/E ratio (TTM) | — | 20.68 |
| Forward P/E | — | 15.35 |
| EPS (TTM) | $-2.23 | $1.08 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $10.64 | $37.77 |
| 52-week low | $4.79 | $14.00 |
| Distance from 52-week high | -16.54% | -40.88% |
| Analyst consensus | buy | none |
| Avg. price target upside | +52.03% | +74.65% |
| Average volume | 681.53K | 298.31K |
| Shares outstanding | 52.87M | 22.65M |
| Employees | 130 | 1,086 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- TCMD has outperformed SENS by 50.8 percentage points over the past year.
About Senseonics
SENS stock →Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. Its products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management.
Health Care · Medical/Dental Instruments · 130 employees
About Tactile Systems Technology
TCMD stock →Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema, phlebolymphedema, lipedema, venous insufficiencies, and other types of edema and leg ulcers; Entre Plus System, a pneumatic compression device for the at-home treatment of lymphedema, chronic edema, venous insufficiency, and chronic wounds.
Health Care · Medical/Dental Instruments · 1,086 employees
SENS vs TCMD FAQ
Which is bigger, Senseonics or Tactile Systems Technology?
Tactile Systems Technology (TCMD) is larger, with a market capitalization of $505.83M compared with $469.52M for Senseonics (SENS).
Which stock has performed better over the past year, SENS or TCMD?
TCMD returned +48.46% over the past 12 months, compared with -2.38% for SENS (price return, excluding dividends). Past performance does not predict future results.
Are Senseonics and Tactile Systems Technology in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.